Mayo Clinic researchers this spring plan to try out Corindus’ telestenting technology — which Mayo officials think could improve care in the rural hospitals in their network, according to a report in the Star Tribune of Minneapolis.
Corindus told MassDevice‘s sister site Medical Design & Outsourcing in 2018 that the company had a partnership with Mayo Clinic to engage pre-clinical testing of its CorPath GRX platform.
The partnership is now moving to the clinical testing phase. A Mayo doctor will initially be in the next room — able to step in if needed — as a percutaneous coronary intervention is performed on a person in need of the procedure. Down the road, though, the doctor may be miles away.
Remote PCI would be a meaningful advance for rural patients who otherwise might face delays receiving emergency cardiac care, lead researcher Dr. Mackram Eleid told the Star Tribune.
Siemens Healthineers in October bought Corindus for $1.1 billion.
Original Article: (https://www.massdevice.com/report-mayo-clinic-to-try-corindus-telestenting-in-rural-settings/)